PCSS-MOUD will be closed for the Holidays We will be closed starting December 24, 2024 and returning January 2, 2025. If you have an emergency, please contact 401-524-0909. Otherwise use our contact us form to send us a message. Please note all certificate requests submitted to PCSS-MOUD during this time will be queued for responses January 2, 2025.

Happy Holidays and Peace to all in the New Year!

Home / Training Courses / Transitioning from Methadone to Buprenorphine

Transitioning from Methadone to Buprenorphine

Audience: Nurses, PAs, Pharmacists, Physicians, Psychiatrists
Organizer(s): American Psychiatric Association
Topic(s): Buprenorphine, Buprenorphine, Full Agonists, Medications, Methadone, Methadone, Opioids, Opioids, Opioids, Partial Agonists, Pharmacology, Transition to MOUD, Treatment, Withdrawal Management
Format: Podcast
Presenter(s): Tim Brennan
Published: May 30, 2019

Credit Available: CE Credit(s): No
Certificate: No

APA’s Medical Mind Podcast

Tim Brennan is director of the Addiction Institute at Mount Sinai West and Mount Sinai St. Luke’s hospitals. He discusses the why and how of transitioning a patient from methadone to buprenorphine, and dispels some common misperceptions that patients and providers have about these treatments.

Listen to Audio

Didn't find what you were looking for?

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Functional

Performance

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Cookie	Duration	Description
VISITOR_INFO1_LIVE	5 months 27 days	A cookie set by YouTube to measure bandwidth that determines whether the user gets the new or old player interface.
YSC	session	YSC cookie is set by Youtube and is used to track the views of embedded videos on Youtube pages.
yt-remote-connected-devices	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.
yt-remote-device-id	never	YouTube sets this cookie to store the video preferences of the user using embedded YouTube video.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

Cookie	Duration	Description
asgarosforum_unread_cleared	15 years 2 months	No description available.

Transitioning from Methadone to Buprenorphine

APA’s Medical Mind Podcast

Didn't find what you were looking for?

Educate. Train. Mentor.

CONTACT

QUICK LINKS